Establishment and prospective validation of an SUV(max) cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by (68)Ga-PSMA PET/CT: a real-world study

Background and Aims: The aims of this study were to establish a maximum standardized uptake value (SUV(max)) cutoff to discriminate clinically significant prostate cancer (csPCa) from benign prostate disease (BPD) by (68)Ga-labeled prostate-specific membrane antigen ((68)Ga-PSMA-11) positron emissio...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Jianhua, Kang, Fei, Zhang, Jingliang, Quan, Zhiyong, Wen, Weihong, Zhao, Xiaohu, Ma, Shuaijun, Wu, Peng, Yang, Fa, Guo, Wei, Yang, Xiaojian, Yuan, Jianlin, Shi, Yongquan, Wang, Jing, Qin, Weijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344003/
https://www.ncbi.nlm.nih.gov/pubmed/34373749
http://dx.doi.org/10.7150/thno.58140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344003/
https://www.ncbi.nlm.nih.gov/pubmed/34373749
http://dx.doi.org/10.7150/thno.58140

Ejemplares similares